Dr. J. Gerardo García-Lerma, PhD, leads the HIV Drug Resistance and Chemoprophylaxis Activity at the Laboratory Branch, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention. His program evaluates the efficacy of antiretroviral pre-exposure prophylaxis (PrEP) in preventing HIV transmission using animal models. Specific areas of research include the evaluation of the efficacy of oral PrEP against wild-type and drug resistant viruses, drug PK/PD studies, and characterization of acute infections.
Dr. García-Lerma joined CDC in 1996 after a post-doctoral stay in Hospital Carlos III in Madrid, Spain. His early research work at CDC was focused on the development of new phenotypic assays to detect drug-resistant viruses, the virologic characterization of transmitted HIV-1 isolates, and the evaluation of dried blood spots for resistance testing. He has a BS and MS in Biology/Biotechnology and a PhD in Immunology from the University Complutense of Madrid.